Abstract
We conducted this case-control study in children (age 3–59 mo) to study the risk factors for failure of standard treatment in severe and very severe community acquired pneumonia. One hundred and eighty one children were enrolled in the study among whom 31 (20.4%) had treatment failure. The independent risk factors for treatment failure by 48 hours using multivariate analysis were: infancy, measles immunization not given by 9 months, severe malnutrition, very fast breathing at baseline, hypoxemia at baseline, and bacteremia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bryce J, Boschi-Pinto C, Shibuya K, Black RE. WHO Child Health Epidemiology Reference Group. WHO estimates of the causes of death in children. Lancet. 2005;365:1147–1452.
Sazawal S, Black RE. Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials. Lancet Infect Dis. 2003;3:547–556.
Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ. 2008; 86: 408–416.
Hazir T, Fox LM, Nisar YB, Fox MP, Ashraf YP, MacLeod WB. New outpatient short-course home oral therapy for severe pneumonia [NO-SHOTS] Study Group. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial. Lancet. 2008; 371: 49–56.
McNally LM, Jeena PM, Gajee K, Thula SA, Sturm AW, Cassol S, et al. Effect of, age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children. Lancet. 2007;369:1440–1451.
Addo-Yobo E, Chisaka N, Hassan M, for the Amoxicillin Penicillin Pneumonia International Study [APPIS] group. Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study. Lancet. 2004;364: 1141–1148.
Fu LY, Ruthazer R, Wilson I, Patel A, Fox LM, Tuan TA, et al. Brief hospitalization and pulse oximetry for amoxycillin treatment failure in severe pneumonia. Pediatrics. 2006;118:e1822–1830.
Asghar R, Banajeh S, Egas J, Hibberd P, Iqbal I, Katep-Bwalya M, et al. Multicentre randomized controlled trial of chloramphenicol vs. ampicillin and gentamicin for the treatment of very severe pneumonia among children aged 2 to 59 months in low resource settings: a multicenter randomized trial [SPEAR study]. BMJ. 2008;336:80–84.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jain, D.L., Sarathi, V. & Jawalekar, S. Predictors of treatment failure in hospitalized children [3–59 months] with severe and very severe pneumonia. Indian Pediatr 50, 787–789 (2013). https://doi.org/10.1007/s13312-013-0220-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-013-0220-z